A-A-0053040(DM)
24 June 1987
INTERIM COMMERCIAL ITEM DESCRIPTION
IOHEXOL INJECTION
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Material, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient characteristics:
Shall be Sterile, Preservative free, Iohexol Injection, in the following concentrations.
Materials used in manufacture shall be of pharmaceutical grade.
For Strength 1, shall contain 180 mg of Iodine per ml of injection, within the applicable assay limits.
For Strength 2, shall contain 240 mg of Iodine per ml of injection, within the applicable assay limits.
For Strength 3, shall contain 300 mg of Iodine per ml of injection, within the applicable assay limits.
For Strength 4, shall contain 350 mg of Iodine per ml of injection, within the applicable assay limits.
Workmanship. The injection shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG).
For Size 1- One package containing ten single dose 10 ml vials, as specified, constitutes one unit.
For Size 2- One package containing ten single dose 20 ml vials, as specified, constitutes one unit.
For Size 1- One package containing ten single dose 50 ml vials, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business